The FAS −670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes
Open Access
- 30 November 2009
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (12) , 3815-3820
- https://doi.org/10.1002/art.24964
Abstract
Objective To investigate the possible role of the FAS −670A>G functional polymorphism in the genetic predisposition to systemic sclerosis (SSc) susceptibility or clinical phenotype. Methods A total of 2,900 SSc patients and 3,186 healthy controls were included in this study. We analyzed the genotype and allele frequencies of the FAS −670A>G polymorphism in 9 distinct ethnic cohorts, including 6 cohorts of European ancestry (a Spanish cohort of 228 SSc patients and 265 controls, a Dutch cohort of 203 SSc patients and 277 controls, a German cohort of 313 SSc patients and 247 controls, an Italian cohort of 323 SSc cases and 89 controls, a British cohort of 269 SSc patients, and a Swedish cohort of 182 patients) and 3 distinct ethnic cohorts from the US (a cohort of 1,047 white patients and 692 controls, a cohort of 159 Hispanic patients and 137 controls, and a cohort of 176 black SSc patients and 194 controls). Genotyping was performed using a TaqMan 5′ allelic discrimination assay. Results In the British, Italian, and American white cohorts we observed an association of the FAS −670G allele with limited cutaneous SSc (lcSSc) (odds ratios [ORs] 1.25, 1.43, and 1.18, respectively). A meta‐analysis comprising all 9 cohorts revealed an association of both the FAS −670G allele (OR 1.10) and the FAS −670GG genotype (OR 1.13) with the lcSSc phenotype. In a meta‐analysis including only white subjects, both the FAS −670G allele and the FAS −670GG genotype remained associated with lcSSc (allele OR 1.12; genotype OR 1.16). In addition, a recessive model of the −670GG genotype exhibited a strong association with SSc, lcSSc, and anticentromere antibody–positive lcSSc (OR 1.23, OR 1.33, and OR 1.45, respectively). Conclusion Our data show that the FAS −670A>G polymorphism plays a role in lcSSc susceptibility. A similar trend has been observed in other autoimmune diseases.Keywords
This publication has 16 references indexed in Scilit:
- The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotypeHuman Molecular Genetics, 2009
- Importance of FAS-1377, FAS-670, and FASL-844 Polymorphisms in Tumor Onset, Progression, and Pigment Phenotypes of Swedish Patients With Melanoma: A Case-Control AnalysisThe Cancer Journal, 2007
- A polymorphism in FAS gene promoter correlated with circulating soluble FAS levelsInternational Journal of Immunogenetics, 2007
- Fas Antigen and Sporadic Alzheimer’s Disease in Southern Italy: Evaluation of Two Polymorphisms in the TNFRSF6 GeneNeurochemical Research, 2007
- A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosisTissue Antigens, 2007
- Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.2006
- Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patientsImmunogenetics, 2005
- Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.Archives of Dermatological Research, 1998
- Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.1988
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980